Egyptian Drug Authority · Egypt
DEA-EG-2026-0176
Tier 1 · Regulator-publishedUnclassifiedسحبStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Not stated by the issuing authority
- Date issued
- 05 Sept 2026
- Recorded by us
- 2026-09-06 19:46:05 UTC
- المستحضر
- Vilaphoria 40 mg
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- الشركة المصنعة
- Rameda
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- أرقام التشغيلات
- Not published with the notice
- تواريخ انتهاء الصلاحية
- Not published with the notice
- Action type
- سحب
- التصنيف
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- خارج المواصفات — المحتوى
- Product type
- دواء
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- نص الإخطار
- Not captured. The notice itself is linked below.
- الحالة
- سارٍ
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 80ca99446e7d6cae7a494cd30c7a009fdc633d634d2f415951c33af762f0c8d9SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-09 18:49:35 UTC
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-EG-2026-0175 | Aug 2026 | EG | Appavisc HVPFS | AVH-051-E | Recall | Class I | Tier 1 · Regulator-published |
| DEA-ZM-2026-40339800 | 13 Feb 2026 | ZM | Sabulin (Salbutamol Tablets BP 4mg) Dawa Ltd , Kenya | 2310025 | Recall | Class I | Tier 1 · Regulator-published |
| DEA-ZM-2026-63941389 | 07 Jan 2026 | ZM | Cloxispa-250 Cloxacillin Capsules BP 250mg Sparsh Bio-Tech Pvt. Ltd., India | CC315 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-KE-2025-0035 | 14 Nov 2025 | KE | Cardoz 12.5 Ipca Laboratories Limited, India | GBC013001 | Recall | Unclassified | Tier 1 · Regulator-published |
| DEA-ZM-0000-42714800 | undated | ZM | KLOXY 250 CLOXACILLIN 250MG CAPSULES LABORATORY AND ALLIED LIMITED KENYA | 86435 | Recall | Class I | Tier 1 · Regulator-published |
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0176: Vilaphoria 40 mg — سحب, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0176Version history
v1Created from the EDA register. No corrections. (correction)
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.